JP Morgan Initiates Coverage On Kura Oncology with Overweight Rating, Announces Price Target of $30
Benzinga Newsdesk 1 month ago
Analyst RatingsNewsInitiationPrice Target
JP Morgan analyst Priyanka Grover initiates coverage on Kura Oncology (NASDAQ:KURA) with a Overweight rating and announces Price Target of $30.
JP Morgan analyst Priyanka Grover initiates coverage on Kura Oncology (NASDAQ:KURA) with a Overweight rating and announces Price Target of $30.